683 Capital Management, LLC Alaunos Therapeutics, Inc. Transaction History

683 Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $395,000 - $535,000	-100,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $206,500 - $347,000	-50,000 Reduced 33.33%	100,000 $428,000
Q2 2019 Aug 14, 2019	SELL	$3.98 - $6.2 $199,000 - $310,000	-50,000 Reduced 25.0%	150,000 $875,000
Q1 2019 May 15, 2019	BUY	$2.0 - $4.4 $400,000 - $880,000	200,000 New	200,000 $770,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $422M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.